You have 9 free searches left this month | for more free features.

City

Shanghai (1)

Condition

Metastatic Liver Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Fudan University (1)

Collaborator

Intervention

haic、bevacizumab、camrelizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

haic、bevacizumab、camrelizumab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Liver Cancer Trial in Shanghai (HAIC?Bevacizumab?Camrelizumab)

Not yet recruiting

Metastatic Liver Cancer

HAIC、Bevacizumab、Camrelizumab

Shanghai, Shanghai, China

Fudan University Shanghai Cancer Center

Dec 7, 2022